Cision PR Newswire

RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias

The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the world's first circular RNA-based in vivo CAR-T therapy achieving FDA IND clearance. RiboX expands its clinical-stage pipeline through its proprietary...

Tuya Smart Co-Founder Alex Yang at Summer Davos 2026: The Future of AI Competition Lies in Real-World Applications

DALIAN, China, June 26, 2026 /PRNewswire/ -- The 17th Annual Meeting of the New Champions (AMNC, also known as "Summer Davos") of the World...

HKEX Welcomes Listing of First ETF Tracking HKEX Tech 100 Index

HONG KONG, June 26, 2026 /PRNewswire/ -- Hong Kong Exchanges and Clearing Limited (HKEX) today (Friday) welcomed the listing of the first exchange traded...

HKEX Welcomes Listing of First ETF Tracking HKEX Tech 100 Index

HONG KONG, June 26, 2026 /PRNewswire/ -- Hong Kong Exchanges and Clearing Limited (HKEX) today (Friday) welcomed the listing of the first exchange traded...

Anime “KAGURABACHI” Casts Katsuyuki Konishi as Togo Shiba; Cast Comments, Character Visual & Trailer Revealed!

~ Crunchyroll Simulcast Confirmed! "Kagurabachi" Anime World Tour Part 1 Confirms Premiere Screening at Otakon! ~ TOKYO, June 26, 2026 /PRNewswire/ -- Anime...

The 4th China International Supply Chain Expo: Healthy Life Chain Unveils Full Spectrum of Global Healthcare Supply Chain Innovation

BEIJING, June 26, 2026 /PRNewswire/ -- The Fourth China International Supply Chain Expo (CISCE) has opened its Healthy Life Chain section, drawing more than...